Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma is a prevalent bone cancer in young individuals.
• Non-coding RNA activated by DNA damage (NORAD) is implicated in cancer cell proliferation.
• The role of NORAD within extracellular vesicles (EVs) from bone mesenchymal stem cells (BMSCs) in osteosarcoma remains underexplored.

Purpose of the Study:

• To investigate the function of NORAD transported via BMSC-derived EVs in osteosarcoma progression.
• To elucidate the molecular mechanism involving NORAD, miR-30c-5p, and KLF10 in osteosarcoma.

Main Methods:

• Isolation and characterization of EVs from BMSCs.
• Co-culture systems to study intercellular transfer of NORAD.
• Bioinformatic analysis, dual luciferase reporter assays, RNA immunoprecipitation, and RNA pull-down assays to validate molecular interactions.
• In vivo mouse models for osteosarcoma growth and metastasis.

Main Results:

• NORAD expression is elevated in osteosarcoma tissues and correlates with disease progression.
• BMSC-derived EVs efficiently transfer NORAD to osteosarcoma cells, enhancing proliferation and invasion.
• NORAD acts as a molecular sponge for miR-30c-5p, leading to increased KLF10 expression.
• In vivo, BMSC-EV administration promoted osteosarcoma growth and metastasis by modulating the NORAD/miR-30c-5p/KLF10 axis.

Conclusions:

• BMSC-derived EVs deliver NORAD to osteosarcoma cells.
• The NORAD/miR-30c-5p/KLF10 axis is a key pathway regulated by BMSC-EVs, driving osteosarcoma progression and metastasis.